在儿科人口中定义Prominauris:系统性审查
Jason Covone1, Gabriel C Bouhadana1, Sabrina Cugno1,2
1Division of Plastic Surgery, Université de Montréal.
The Journal of craniofacial surgery
|March 3, 2026
概括
突出的耳朵 (prominauris) 没有标准的分类. 这项研究提出了一个新的客观系统,考虑年龄和性别,以更好地诊断儿童患者的诊断和手术规划.
科学领域:
- 儿童整形外科 儿童整形外科
- 头骨面部形症 头骨面部形症
- 人类测量学 人类测量学.
背景情况:
- 突出耳朵 (prominauris) 是一个常见的儿科头骨面部形.
- 心理社会困扰通常与prominauris有关.
- 目前的分类系统缺乏标准化和人口因素 (年龄,性别).
研究的目的:
- 系统地审查现有的prominauris分类系统.
- 提出一个新的,客观的,和实用的分类框架,为 prominauris.
主要方法:
- 对MEDLINE,Embase,CINAHL和Cochrane试验的系统审查,用于儿科prominauris分类.
- 数据提取和15项研究的批判性评估包括使用6个预定义标准的研究.
- 基于形-螺旋距离的新2步分类的开发.
主要成果:
- 现有的分类是高度可变的,依赖于主观评估 (47%) 或物理测量 (40%).
- 很少有系统将年龄 (1) 或性别 (1) 纳入,没有一个系统将两者兼容.
- 拟议的系统使用特定于年龄和性别的形形距离的门值.
结论:
- 目前的prominauris分类系统不一致,缺乏人口变化.
- 拟议的分类提供了一个简单,可复制和客观的方法.
- 这一新系统旨在改善儿科前科患者的诊断一致性和手术决策.
相关概念视频
Pharmacokinetics in Pediatric Patients: Drug Excretion
340
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
340
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
446
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
446
Pharmacokinetics in Pediatric Patients: Drug Metabolism
294
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
294
Pharmacokinetics in Pediatric Patients: Drug Distribution
388
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
388
Drug Dosing: Infants and Children
457
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
457
Methods of Documentation II: POMR
1.5K
The Problem-Oriented Medical Record (POMR) revolutionized medical record-keeping by introducing a systematic approach focusing on the patient's problems rather than merely listing symptoms. Dr. Lawrence Weed's introduction of this method in the 1960s marked a significant advancement in medical documentation. The POMR framework consists of four key components: the database, problem list, plan of care, and progress notes.
1.5K


